Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities

por Díaz-Dinamarca, Diego A., Salazar, Michelle L., Castillo, Byron N., Manubens, Augusto, Vasquez, Abel E., Salazar, Fabián, Becker, María Inés
Publicado 2022

Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model

por Diaz-Dinamarca, Diego A., Hernandez, Carlos, Escobar, Daniel F., Soto, Daniel A., Muñoz, Guillermo A., Badilla, Jesús F., Manzo, Ricardo A., Carrión, Flavio, Kalergis, Alexis M., Vasquez, Abel E.
Publicado 2020

Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways

por Díaz-Dinamarca, Diego A., Salazar, Michelle L., Escobar, Daniel F., Castillo, Byron N., Valdebenito, Bastián, Díaz, Pablo, Manubens, Augusto, Salazar, Fabián, Troncoso, Mayarling F., Lavandero, Sergio, Díaz, Janepsy, Becker, María Inés, Vásquez, Abel E.
Publicado 2023

Development and analytical validation of real-time PCR for the detection of Streptococcus agalactiae in pregnant women

por Escobar, Daniel F., Diaz-Dinamarca, Diego A., Hernández, Carlos F., Soto, Daniel A., Manzo, Ricardo A., Alarcón, Pedro I., Pinto, Camila H., Bastias, Diego N., Oberg-Bravo, Carolayn N., Rojas, Robert, Illanes, Sebastián E., Kalergis, Alexis M., Vasquez, Abel E.
Publicado 2020

Surface Immunogenic Protein of Streptococcus Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant

por Diaz-Dinamarca, Diego A., Manzo, Ricardo A., Soto, Daniel A., Avendaño-Valenzuela, María José, Bastias, Diego N., Soto, Paulina I., Escobar, Daniel F., Vasquez-Saez, Valeria, Carrión, Flavio, Pizarro-Ortega, Magdalena S., Wilson, Christian A. M., Berrios, Julio, Kalergis, Alexis M., Vasquez, Abel E.
Publicado 2020

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

por Díaz-Dinamarca, Diego A., Díaz, Pablo, Barra, Gisselle, Puentes, Rodrigo, Arata, Loredana, Grossolli, Jonnathan, Riveros-Rodriguez, Boris, Ardiles, Luis, Santelises, Julio, Vasquez-Saez, Valeria, Escobar, Daniel F., Soto, Daniel, Canales, Cecilia, Díaz, Janepsy, Lamperti, Liliana, Castillo, Daniela, Urra, Mychel, Zuñiga, Felipe, Ormazabal, Valeska, Nova-Lamperti, Estefanía, Benítez, Rosana, Rivera, Alejandra, Cortes, Claudia P., Valenzuela, María Teresa, García-Escorza, Heriberto E., Vasquez, Abel E.
Publicado 2023